2024-03-29T10:25:31Zhttps://kuscholarworks.ku.edu/oai/requestoai:kuscholarworks.ku.edu:1808/11612019-04-12T14:36:07Zcom_1808_1052com_1808_1049col_1808_1061
Yamashita, Shinji
2006-11-19T20:53:59Z
2006-11-19T20:53:59Z
2006-10-26
http://hdl.handle.net/1808/1161
openAccess
Oral Drug Absorption
Presentation
oai:kuscholarworks.ku.edu:1808/11592019-04-12T14:36:08Zcom_1808_1052com_1808_1049col_1808_1061
Dahan, Arik
2006-11-19T20:50:19Z
2006-11-19T20:50:19Z
2006-10-26
http://hdl.handle.net/1808/1159
openAccess
Advantages and Limitations of an In Vitro Lipolysis Model as a Predictive Tool in the Development of Lipid Based Oral Formulations or Lipophilic Drugs
Presentation
oai:kuscholarworks.ku.edu:1808/11602019-04-12T14:35:06Zcom_1808_1052com_1808_1049col_1808_1061
Endres, Christopher J.
2006-11-19T20:52:27Z
2006-11-19T20:52:27Z
2006-10-26
http://hdl.handle.net/1808/1160
openAccess
The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Ribavirin Disposition in Mice
Presentation